Showing results (31-40 of 76) with videos related to
Sort By:
Pageof 8
The Journal of Biological Chemistry|December 13, 2006
Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: relevance to Parkinson diseaseNoriyuki Yamamoto, Hideyuki Sawada, Yasuhiko Izumi, et al.Expert Opinion on Pharmacotherapy|June 26, 2018
Pharmacological interventions for anxiety in Parkinson's disease sufferersHideyuki Sawada, Atsushi Umemura, Masayuki Kohsaka, et al.Plos One|April 25, 2013
Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's diseaseAtsushi Umemura, Tomoko Oeda, Ryutaro Hayashi, et al.Journal of Neuroscience Research|August 19, 2005
Iron accelerates the conversion of dopamine-oxidized intermediates into melanin and provides protection in SH-SY5Y cellsYasuhiko Izumi, Hideyuki Sawada, Noriyuki Yamamoto, et al.Biomimetics (Basel, Switzerland)|March 27, 2024
Anatomically-Inspired Robotic Finger with SMA Tendon Actuation for Enhanced Biomimetic FunctionalityRenke Liu, Huakai Zheng, Maroš Hliboký, et al.European Journal of Pharmacology|May 13, 2010
Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transportTakaaki Matsuo, Yasuhiko Izumi, Seiko Wakita, et al.Journal of Neuroscience Methods|August 3, 2010
Reconstruction and quantitative evaluation of dopaminergic innervation of striatal neurons in dissociated primary culturesSeiko Wakita, Yasuhiko Izumi, Takaaki Matsuo, et al.Biochemical and Biophysical Research Communications|April 13, 2005
Stimulation of nicotinic acetylcholine receptors protects motor neuronsTomoki Nakamizo, Jun Kawamata, Hirofumi Yamashita, et al.BMC Neurology|October 15, 2013
Trigger medications and patient-related risk factors for Parkinson disease psychosis requiring anti-psychotic drugs: a retrospective cohort studyHideyuki Sawada, Tomoko Oeda, Kenji Yamamoto, et al.Journal of Neuroscience Research|October 23, 2002
Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascadeTakeshi Kihara, Shun Shimohama, Hideyuki Sawada, et al.Pageof 8